Synthesis and biological evaluation of novel 2-deoxy-4-thio-imidazole nucleosides. 1999

Y Wang, and G Inguaggiato, and M Jasamai, and M Shah, and D Hughes, and M Slater, and C Simons
Welsh School of Pharmacy, Cardiff University, UK.

A study on the use of 3'-directing groups for the synthesis of imidazole 2'-deoxy-4'-thionucleosides led to varying alpha:beta ratios in the glycosylation reaction. The para-nitrobenzoyl group gave the optimum result in the glycosylation step; therefore, this protected thiosugar 10b was used for the synthesis of a series of novel 2'-deoxy-4'-thio-imidazole nucleosides which have been evaluated for antiviral activity in vitro.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D006031 Glycosylation The synthetic chemistry reaction or enzymatic reaction of adding carbohydrate or glycosyl groups. GLYCOSYLTRANSFERASES carry out the enzymatic glycosylation reactions. The spontaneous, non-enzymatic attachment of reducing sugars to free amino groups in proteins, lipids, or nucleic acids is called GLYCATION (see MAILLARD REACTION). Protein Glycosylation,Glycosylation, Protein
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Y Wang, and G Inguaggiato, and M Jasamai, and M Shah, and D Hughes, and M Slater, and C Simons
January 1999, Nucleosides & nucleotides,
Y Wang, and G Inguaggiato, and M Jasamai, and M Shah, and D Hughes, and M Slater, and C Simons
August 1991, Journal of medicinal chemistry,
Y Wang, and G Inguaggiato, and M Jasamai, and M Shah, and D Hughes, and M Slater, and C Simons
January 2005, Nucleosides, nucleotides & nucleic acids,
Y Wang, and G Inguaggiato, and M Jasamai, and M Shah, and D Hughes, and M Slater, and C Simons
January 1996, Journal of medicinal chemistry,
Y Wang, and G Inguaggiato, and M Jasamai, and M Shah, and D Hughes, and M Slater, and C Simons
January 1999, Nucleosides & nucleotides,
Y Wang, and G Inguaggiato, and M Jasamai, and M Shah, and D Hughes, and M Slater, and C Simons
January 2009, Nucleic acids symposium series (2004),
Y Wang, and G Inguaggiato, and M Jasamai, and M Shah, and D Hughes, and M Slater, and C Simons
June 2010, Chemical biology & drug design,
Y Wang, and G Inguaggiato, and M Jasamai, and M Shah, and D Hughes, and M Slater, and C Simons
March 1999, Nucleosides & nucleotides,
Y Wang, and G Inguaggiato, and M Jasamai, and M Shah, and D Hughes, and M Slater, and C Simons
July 2000, Bioorganic & medicinal chemistry,
Y Wang, and G Inguaggiato, and M Jasamai, and M Shah, and D Hughes, and M Slater, and C Simons
January 2001, Nucleosides, nucleotides & nucleic acids,
Copied contents to your clipboard!